# Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/fresolimumab-treatment-decreases-biomarkers-and-improves-clinical-symptoms-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lisa Rice,Cristina M. Padilla,Sarah McLaughlin,Allison L. Mathes,Jessica Ziemek,Salma Goummih,Sashidhar Nakerakanti,Michael York,Giuseppina Farina,Michael L. Whitfield,Robert Spiera,Romy Christmann,Jessica Gordon,Janice Weinberg,Robert W. Simms,Robert Lafyatis |
| Citations | 345 |
| DOI | 10.1172/jci77958 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jci.org/articles/view/77958/files/pdf |
| OpenAlex ID | https://openalex.org/W2155049325 |
| PMID | 26098215 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Janice Weinberg](https://scholariq.org/researchers/janice-weinberg/)
- [Sarah McLaughlin](https://scholariq.org/researchers/sarah-mclaughlin/)

## Paper primary topic

- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

## Paper topics

- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Connective Tissue Growth Factor Research](https://scholariq.org/topics/connective-tissue-growth-factor-research/)
- [Skin Diseases and Diabetes](https://scholariq.org/topics/skin-diseases-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.